Multicenter, Post-marketing, Non-interventional, Observational Study in RA Patients Treated With RoActemra/Actemra (Tocilizumab)
Clinical trial NCT02101307 · COMPLETED
Trial details
- NCT number
- NCT02101307
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-07-09
- Primary completion
- 2017-05-22
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.